Financial News
Latest News about MRK
Recent news which mentions MRK
FDA Approves Another COVID-19 Antiviral Pill, This Time From Merck
December 23, 2021
From Benzinga
Investors Appear Uninterested in Bonds Despite Elevated Uncertainty
December 22, 2021
From Benzinga
From Benzinga
FDA To Possibly Authorize Pfizer, Merck COVID-19 Antiviral Pills This Week: Bloomberg
December 22, 2021
From Benzinga
UK Calls For Additional Doses Of COVID-19 Antivirals From Merck, Pfizer
December 22, 2021
From Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
From Benzinga
Why growth and dividend stocks will be hot items for 2022, along with these super-productive companies
December 22, 2021
From MarketWatch
Buy Palantir Stock While the Analysts Remain Bearish
December 22, 2021
From InvestorPlace
From Benzinga
Bristol Myers Squibb Stock: Bull vs. Bear
December 21, 2021
From Motley Fool
Will Eli Lilly Be a Top Pharma Stock Again in 2022?
December 19, 2021
From Motley Fool
EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer
December 17, 2021
Tickers
MRK
From Benzinga
From Benzinga
These 2 Dividend ETFs Are a Retiree's Best Friend
December 17, 2021
From Motley Fool
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
From Benzinga
Why This Once-Promising HIV Candidate Could Be in Trouble
December 17, 2021
Tickers
MRK
From Motley Fool
Is Merck's Dig at Pfizer's COVID-19 Pill Justified?
December 17, 2021
From Motley Fool
3 COVID Stocks That Will Pay You Rich Dividends in 2022
December 16, 2021
From Motley Fool
2 Dirt-Cheap Growth Stocks Trading Near Their 52-Week Lows
December 16, 2021
From Motley Fool
EU meets to discuss response to omicron variant as France restricts travel from UK, and CDC panel to discuss rare side effect from J&J vaccine
December 16, 2021
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021
December 16, 2021
From Benzinga
Some ETFs mix investing with charities — should you?
December 16, 2021
From MarketWatch
Is It Time to Buy the 8 Worst-Performing Dividend Stocks of 2021?
December 15, 2021
From Motley Fool
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
From Benzinga
CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021
December 14, 2021
From Benzinga
From Motley Fool
The Use of High Pressure is Transforming the Nutraceuticals (CBD), Food & Beverage, Healthcare, and other Billion-Dollar Markets
December 14, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2021
December 13, 2021
From Benzinga
Merck Raises $1 Billion Via Inaugural Sustainability Bond
December 13, 2021
Tickers
MRK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
